---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009912"
form_type: "8-K"
ticker: "IRIX"
cik: "0001006045"
company_name: "IRIDEX CORP"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:45:36.598647+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Iridex Q4 2025 revenue up 15-17% YoY to ~$14.7M; positive cash flow in quarter

## Summary
- Q4 2025 revenue expected $14.6-14.8M vs $12.7M prior year, +15-17% YoY.
- Full-year 2025 revenue expected $52.5-52.7M vs $48.7M in 2024, +8% YoY.
- Achieved positive cash flow in Q4 and expects positive adjusted EBITDA for full-year 2025.
- Sold 15,800 Cyclo G6 probes in Q4 (up 19% YoY); 44 systems sold vs 47 prior year.
- CEO cites cost reductions, gross margin expansion, and improved commercial efficiency as drivers.

## SEC filing metadata
- accession: 0001193125-26-009912
- form_type: 8-K
- ticker: IRIX
- cik: 0001006045
- company_name: IRIDEX CORP
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006045/000119312526009912/0001193125-26-009912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006045/000119312526009912/irix-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009912
- JSON: https://secwatch.observer/filing/0001193125-26-009912.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009912.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.